CVX Chevron Corp. $CVX Company Overview Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
CVX Chevron Corp. $CVX Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=CVX&...mp;yt0=Go!

Last Updated: 12/31/2015 12:15:32

Current Price and Quotes
Last Price 90.50
Previous Close 90.09 Open 89.38
Daily Range 89.022 - 90.86 52wk Range 69.58 - 113.31
Volume 3,372,700 Dividend 4.28
Average Vol (30d) 10,636,693 Net Dividend Yield 4.7293




Financials
Period Ending Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 200,494,000 220,156,000 230,590,000 244,371,000
Cost of Revenue 144,956,000 159,323,000 163,336,000 171,572,000
Gross Profit 55,538,000 60,833,000 67,254,000 72,799,000
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 17,034,000 17,573,000 17,100,000 20,373,000
Non-Recurring Items 1,985,000 1,861,000 1,728,000 1,216,000
Other 16,793,000 14,186,000 13,413,000 12,911,000
Operating Income 19,726,000 27,213,000 35,013,000 38,299,000
Income From Continuing Operations

Add'l Income/Expense Items 4,378,000 1,165,000 4,430,000 1,972,000
Earnings Before Interest and Tax 31,202,000 35,905,000 46,332,000 47,634,000
Interest Expense - - - -
Earnings Before Tax 31,202,000 35,905,000 46,332,000 47,634,000
Income Tax 11,892,000 14,308,000 19,996,000 20,626,000
Minority Interest 69,000 174,000 157,000 113,000
Equity Earnings Unconsolidated Subsidiary 7,098,000 7,527,000 6,889,000 7,363,000
Net Income Cont. Operations 26,339,000 28,950,000 33,068,000 34,258,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 19,241,000 21,423,000 26,179,000 26,895,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 19,241,000 21,423,000 26,179,000 26,895,000

Recent News

CVX Chevron Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CVX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CVX/quote
Stock Chart http://www.otcmarkets.com/stock/CVX/chart
Company Info http://www.otcmarkets.com/stock/CVX/company-info
Recent News http://www.otcmarkets.com/stock/CVX/news
Financials http://www.otcmarkets.com/stock/CVX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CVX/filings
Short Sales http://www.otcmarkets.com/stock/CVX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CVX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CVX/research
Summary http://finance.yahoo.com/q?s=CVX
Historical Prices http://finance.yahoo.com/q/hp?s=CVX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CVX
Basic Chart http://finance.yahoo.com/q/bc?s=CVX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CVX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CVX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CVX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CVX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CVX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CVX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CVX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CVX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CVX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CVX
Balance Sheet http://finance.yahoo.com/q/bs?s=CVX
Cash Flow http://finance.yahoo.com/q/cf?s=CVX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CVX
Market Watch http://www.marketwatch.com/investing/stock/CVX
Bloomberg http://www.bloomberg.com/quote/CVX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CVX
Bussinessweek http://investing.businessweek.com/research/st...ticker=CVX
Barchart http://www.barchart.com/quotes/stocks/CVX
OTC Short Report http://otcshortreport.com/index.php?index=CVX
Investopedia http://www.investopedia.com/markets/stocks/CVX/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 154

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 27

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 129

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 150

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading

Top 5 Most Recently Viewed Articles

Coca-Cola's Emerging Markets Strategy Fuels Long-Term Growth

Updated Category News Views 929

Coca-Cola's Position in Emerging Markets Coca-Cola Co (NYSE: KO) stands as a beacon of growth, with a visionary strategy that highlights both immediate and long-term opportunities. The company has successfully positioned itself in vital markets, particularly in North America and Latin America, which have proven central to its success. According to recent insights from...

Continue Reading
Voda IQ Appoints Armando Piccinini to Drive European Sales

Updated Category News Views 121

Voda IQ dropped some big news back in 2024 when they appointed Armando Piccinini as their European Sales Director. This guy’s got over twenty years under his belt in aquatic conservation, which they clearly hope will ramp up their sales strategy across Europe. But you gotta wonder—are the numbers behind this move really there? Can Experience Translate to Sales Growth?...

Continue Reading
Magnera Corporation to Shine at Upcoming Finance Conference

Updated Category News Views 163

Magnera Corporation's Conference Participation Announcement Magnera Corporation (NYSE: MAGN) has made an exciting announcement regarding its upcoming participation in a significant financial event. The company is set to be a part of the 2025 Bank of America Leveraged Finance Conference, aimed at fostering connections with top institutional investors. The event will take...

Continue Reading
Bullish Momentum Unveiled: Insights on Merck & Co Stocks

Updated Category News Views 180

Exciting Developments in Merck & Co Options Activity Notable investors are expressing strong optimism about Merck & Co. A recent analysis of options trading strategies reveals a wave of activity among traders aiming to capitalize on this potential. Options Trading Overview When reviewing the options history for Merck & Co (NYSE: MRK), we found a total of 33 trades that...

Continue Reading
Gilead Snags Arcellx: A High-Stakes Cancer Gamble Unfolds

Updated Category News Views 195

The Big Play for Cancer Innovation Gilead Sciences Inc. (NASDAQ:GILD) pulled the trigger on a pretty huge acquisition deal, landing Arcellx Inc. (NASDAQ:ACLX) this past Monday for a staggering $115 per share, which gets better with a potential extra $5 per share on a contingent value right. That rings in a hefty total of $7.8 billion—no pocket change, folks. What’s...

Continue Reading